Does Humana Gold Plus Cover Rybelsus? Medicare Advantage Coverage Guide 2026
If you’re enrolled in with Gold Plus HMO (from Humana) commonly wonder whether the formulary covers Rybelsus (oral semaglutide). The short answer is: coverage depends on specific formulary placement and clinical criteria.
Humana Gold Plus’s Formulary Position on Rybelsus
Gold Plus HMO maintains a prescription drug list that classifies medications based on coverage level. As of 2026, Rybelsus is typically classified as Tier 5 (Non-preferred specialty) for typical Humana Gold Plus plan designs.
What this means for you:
- Out-of-pocket cost: significant cost-sharing varying by plan variant and drug tier
- Prior authorization: Yes — a PA request is needed
- Quantity limits: Common — typically one pen/month
- Step therapy: Could demand trying metformin, insulin, or other treatments first
In the donut hole phase, enrollees pay a larger share until catastrophic coverage kicks in.
Coverage for FDA-Approved vs. Off-Label Use
For type 2 diabetes (FDA-approved):
- Humana Gold Plus is more likely to approve Rybelsus for on-label use
- Documentation needed: clinical records showing medical necessity
- Approval rates are higher with proper documentation
For weight loss (where applicable):
- Traditional Medicare does not cover anti-obesity medications under Part D
- An exception exists: recent CMS guidance may have changed formulary inclusion rules for weight management medications
- Humana Gold Plus may offer supplemental benefits that include weight management medications — check your Evidence of Coverage document
Estimated Costs With Humana Gold Plus
Estimating your out-of-pocket cost for Rybelsus on Humana Gold Plus involves where you are in the benefit structure.
| Coverage Phase | Typical Cost |
|---|---|
| Initial Deductible ($590 in 2026) | Full retail price: $900–$1,100/month |
| Initial Coverage | Tier 4/5 copay |
| Coverage Gap (Donut Hole) | ~$250–$350/month |
| Catastrophic Coverage | Minimal cost |
The IRA’s $2,000 annual cap, total OOP costs won’t exceed $2,000 — providing substantial relief to anyone taking Rybelsus.
Navigating the PA Process
- Ask for a tier exception — When cost is prohibitive, your provider can submit a tier reduction or formulary exception with clinical justification
- Use Novo Nordisk’s savings programs — Novo Nordisk provides copay cards for eligible Medicare enrollees (government plan restrictions may apply)
- Switch plans if needed — Open enrollment (Oct 15–Dec 7) is your chance to find a better-tier placement
- Explore LIS — Low-income beneficiaries can get reduced Part D costs that significantly reduce out-of-pocket expenses